POSITION：HOME > Chinese Medicines> Adebrelimab> Adebrelimab Medication Q&A
Adebrelimab
Adebrelimab

Adebrelimab(阿得贝利单抗注射液)

Adebrelimab is the first domestically developed PD-L1 inhibitor in China to be approved for the indication of extensive-stage small cell lung cancer, and it achieves improved safety and a more pure pharmacological effect through dual molecular modifications.

  • 600mg(12ml)/vial

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.
Authentic
Guarantee
Fast Delivery
Privacy

Adebrelimab Medication Q&A

There is no data in this category！

Recommended

Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH

whatsAppIcon

Order on WhatsApp